Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2017 1
2018 2
2019 1
2020 2
2022 1
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
Sonneveld P, Dimopoulos MA, Boccadoro M, Quach H, Ho PJ, Beksac M, Hulin C, Antonioli E, Leleu X, Mangiacavalli S, Perrot A, Cavo M, Belotti A, Broijl A, Gay F, Mina R, Nijhof IS, van de Donk NWCJ, Katodritou E, Schjesvold F, Sureda Balari A, Rosiñol L, Delforge M, Roeloffzen W, Silzle T, Vangsted A, Einsele H, Spencer A, Hajek R, Jurczyszyn A, Lonergan S, Ahmadi T, Liu Y, Wang J, Vieyra D, van Brummelen EMJ, Vanquickelberghe V, Sitthi-Amorn A, de Boer CJ, Carson R, Rodriguez-Otero P, Bladé J, Moreau P; PERSEUS Trial Investigators. Sonneveld P, et al. N Engl J Med. 2024 Jan 25;390(4):301-313. doi: 10.1056/NEJMoa2312054. Epub 2023 Dec 12. N Engl J Med. 2024. PMID: 38084760 Clinical Trial.
[Neurogenic autonomic dysfunction in adults].
Terkelsen AJ, Hansen J, Klostergaard A, Otto M, Mølgaard H, Hvas CL, Krogh K, Kirkeby HJ, Andersen H, Jensen TS. Terkelsen AJ, et al. Among authors: klostergaard a. Ugeskr Laeger. 2018 Apr 30;180(18):V08170612. Ugeskr Laeger. 2018. PMID: 29720343 Free article. Review. Danish.
Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13.
Groen K, Schjesvold FH, van der Holt B, Levin MD, Seefat MR, Hansson M, Leys MBL, Regelink JC, Waage A, Szatkowski D, Axelsson P, Hieu Do T, Svirskaite A, van der Spek E, Haukas E, Knut-Bojanowska D, Ypma PF, Blimark CH, Mellqvist UH, van de Donk NWCJ, Sonneveld P, Klostergaard A, Vangsted AJ, Abildgaard N, Zweegman S. Groen K, et al. Among authors: klostergaard a. Hemasphere. 2023 Aug 30;7(9):e940. doi: 10.1097/HS9.0000000000000940. eCollection 2023 Sep. Hemasphere. 2023. PMID: 37663673 Free PMC article. No abstract available.
[Neurogenic autonomic dysfunction in primary amyliodosis].
Terkelsen AJ, Hansen J, Klostergaard A, Otto M, Mølgaard H, Hvas CL, Krogh K, Kirkeby HJ, Madsen LB, Andersen H, Jensen TS. Terkelsen AJ, et al. Among authors: klostergaard a. Ugeskr Laeger. 2018 Apr 2;180(14):V12170927. Ugeskr Laeger. 2018. PMID: 29622069 Free article. Danish.
Strategies to improve patient-reported outcome completion rates in longitudinal studies.
Nielsen LK, King M, Möller S, Jarden M, Andersen CL, Frederiksen H, Gregersen H, Klostergaard A, Steffensen MS, Pedersen PT, Hinge M, Frederiksen M, Jensen BA, Helleberg C, Mylin AK, Abildgaard N. Nielsen LK, et al. Among authors: klostergaard a. Qual Life Res. 2020 Feb;29(2):335-346. doi: 10.1007/s11136-019-02304-8. Epub 2019 Sep 23. Qual Life Res. 2020. PMID: 31549365 Free PMC article.
Geographical and ecological analyses of multiple myeloma in Denmark: Identification of potential hotspot areas and impact of urbanisation.
Bertelsen LD, Børty Nielsen L, Christensen HS, Bøgsted M, Gregersen H, Pedersen RS, Klostergaard A, Schnack BI, Pedersen PT, Abildgaard N, Hermansen E, Vangsted AJ, Severinsen MT. Bertelsen LD, et al. Among authors: klostergaard a. Eur J Haematol. 2023 Mar;110(3):289-295. doi: 10.1111/ejh.13904. Epub 2022 Dec 4. Eur J Haematol. 2023. PMID: 36413106 Free PMC article.
Ixazomib-Thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; results from the randomized phase II HOVON-126/NMSG 21.13 trial.
Zweegman S, Stege CAM, Haukas E, Schjesvold FH, Levin MD, Waage A, Leys RBL, Klein SK, Szatkowski D, Axelsson P, Hieu Do T, Knut-Bojanowska D, van der Spek E, Svirskaite A, Klostergaard A, Salomo M, Blimark C, Ypma PF, Mellqvist UH, Poddighe PJ, Stevens-Kroef M, van de Donk NWCJ, Sonneveld P, Hansson M, van der Holt B, Abildgaard N. Zweegman S, et al. Among authors: klostergaard a. Haematologica. 2020 Dec 1;105(12):2879-2882. doi: 10.3324/haematol.2019.240374. Haematologica. 2020. PMID: 33256392 Free PMC article. Clinical Trial. No abstract available.
Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population.
Sørrig R, Klausen TW, Salomo M, Vangsted AJ, Frølund UC, Andersen KT, Klostergaard A, Helleberg C, Pedersen RS, Pedersen PT, Helm-Petersen S, Teodorescu EM, Preiss B, Abildgaard N, Gimsing P; Danish Myeloma Study Group. Sørrig R, et al. Among authors: klostergaard a. PLoS One. 2017 Dec 7;12(12):e0188988. doi: 10.1371/journal.pone.0188988. eCollection 2017. PLoS One. 2017. PMID: 29216227 Free PMC article.